David Urech Founder of Numab Backed byBiotechnology Value FundNovo HoldingsKasim KutayMark Nathan Lampert LinkedIn SourcesNumab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing — 2025-01 Browse all founders · Browse investors
